Welcome to our dedicated page for Pebblebrook Hotel Trust SEC filings (Ticker: PEB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Pebblebrook Hotel Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Pebblebrook Hotel Trust's regulatory disclosures and financial reporting.
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh report their holdings in Pebblebrook Hotel Trust common shares on an amended Schedule 13G. They collectively report beneficial ownership of 2,451,933 common shares, representing 2.16% of the class.
The group reports no sole voting or dispositive power over these shares and shared voting and dispositive power over all 2,451,933 shares. The filing indicates that the reporting persons hold 5 percent or less of the class of Pebblebrook Hotel Trust common shares.
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 5,451,790 shares of Pebblebrook Hotel Trust, representing 4.8% of the class. It has sole power to vote 5,419,396 shares and sole power to dispose of 5,451,790 shares, with no shared voting or dispositive power. The filer notes that it now holds 5 percent or less of the class and expressly denies being the beneficial owner of the securities for certain legal purposes.
T. Rowe Price Associates, Inc. reported beneficial ownership of 8,581,279 shares of Pebblebrook Hotel Trust common stock, representing 7.6% of the class. The firm reports sole voting power over 8,567,433 shares and sole dispositive power over 8,581,279 shares, with no shared voting or dispositive power. T. Rowe Price Associates states that this reporting shall not be construed as an admission that it is the beneficial owner of these securities and expressly denies such beneficial ownership.
Bank of America Corporation, through certain wholly owned subsidiaries, reported beneficial ownership of 4,113,311 Pebblebrook Hotel Trust common shares, representing 3.7% of the class, based on 112,451,844 shares outstanding as of June 30, 2026. The reporting group has shared voting power over 3,580,832 shares and shared dispositive power over 3,592,043 shares, with no sole voting or dispositive power. The filing is made on behalf of Bank of America Corporation and subsidiaries including BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, Merrill Lynch Pierce Fenner & Smith, Inc., and U.S. Trust Co. of Delaware.
Pebblebrook Hotel Trust Co-President and Chief Investment Officer Thomas Charles Fisher sold 40,000 common shares on August 3, 2026 at a weighted average price of $19.253 per share, in multiple trades between $19.16 and $19.37. Following the sale, he directly holds 285,163 common shares. He also holds vested LTIP Class A Units representing 9,469 underlying common shares and LTIP Class B Units representing 250,852 underlying common shares, which are at parity with Operating Partnership units and exchangeable one-for-one for units or, at the partnership’s option, an equivalent amount of cash, with no expiration date.
A holder of Pebblebrook Hotel Trust (symbol PEB) common stock has filed notice of a proposed sale of up to 40,000 common shares on the NYSE through Raymond James and Associates Inc., with an estimated aggregate value of $770,104.13 as of 08/03/2026. The shares trace back to multiple performance-based compensation awards granted by the issuer between 2014 and 2019.
Pebblebrook Hotel Trust reported strong Q2 2026 results, with net income of $24.9 million and Same-Property Hotel EBITDA of $123.3 million, 7.1% above Q2 2025 and $6.6 million above the high end of its outlook. Same-Property RevPAR rose 6.5% on higher room rates and modest occupancy gains, driving Same-Property Hotel EBITDA margin to 30.6%, up 67 basis points. Adjusted EBITDA re was $116.2 million and Adjusted FFO per diluted share was $0.68, $0.06 over the high end of guidance.
Resorts and San Francisco led growth, while Washington, DC and urban San Diego faced demand headwinds. The balance sheet strengthened, with net debt to trailing 12‑month corporate EBITDA at 5.3x and cash and restricted cash of $270.4 million; the remaining $350 million of December 2026 convertible notes are fully funded and no other maturities occur until 2028. The company sold the Chamberlain West Hollywood Hotel for $43.5 million and retired preferred shares at a 23% discount, repurchased 0.5 million common and 1.5 million preferred shares in Q2, and authorized a new preferred share repurchase program of up to $50.0 million. Pebblebrook raised its 2026 outlook, targeting Adjusted EBITDA re of $345.0–$353.0 million and Adjusted FFO per diluted share of $1.69–$1.76.
Pebblebrook Hotel Trust, a lodging-focused REIT, reported second-quarter 2026 net income attributable to common shareholders of $20,659 (in thousands) versus $7,424 (in thousands) a year earlier, as revenues were essentially flat while hotel operating expenses, depreciation and interest costs declined.
Same-property performance improved, with occupancy, average daily rate and RevPAR all higher and Hotel EBITDA reaching $123,822 (in thousands). Management highlights strong growth at resort assets and a continuing recovery in San Francisco, Chicago, Los Angeles and Boston, while remaining cautious about the macroeconomic environment.
The company ended June 30, 2026 with total debt principal of $2,103,925 (in thousands) and no borrowings on its $650.0 million senior unsecured revolving credit facility, after extending a $360.0 million term loan to 2031 and repaying a $40.0 million mortgage. It also sold the Chamberlain West Hollywood Hotel for $43.5 million and repurchased 944,452 common shares for $12.9 million and 1,487,038 preferred shares for $28.6 million, while recording an $8.8 million impairment on one hotel.
Pebblebrook Hotel Trust’s Chairman and CEO Jon E. Bortz reported an open-market purchase of 20,000 Common Shares at $18.18 per share. After this trade, his directly held Common Shares total 1,657,110, alongside 18,000 5.70% Series H Preferred Shares and 643,500 LTIP Class B Units that are tied to an equivalent number of Common Shares. An additional 200,000 Common Shares are held indirectly by his wife, and the footnote states he disclaims beneficial ownership of those shares.
Pebblebrook Hotel Trust declared cash dividends for the second quarter of 2026 on its common and preferred shares. The company will pay a quarterly dividend of $0.01 per common share on July 15, 2026 to shareholders of record on June 30, 2026.
The Board also approved regular quarterly dividends on its preferred shares: $0.39844 per 6.375% Series E share, $0.39375 per 6.30% Series F share, $0.39844 per 6.375% Series G share, and $0.35625 per 5.70% Series H share, each payable on July 15, 2026 to holders of record on June 30, 2026.